Ticker Details
ARS Pharmaceuticals, Inc.
IPO Date:	December 4, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$788.47M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.28 | 2.92%
Avg Daily Range (30 D):	$0.22 | 2.75%
Avg Daily Range (90 D):	$0.23 | 2.64%

Institutional Daily Volume
Avg Daily Volume:	.7M
Avg Daily Volume (30 D):	1.59M
Avg Daily Volume (90 D):	1.31M

Trade Size
Avg Trade Size (Sh.):	90
Avg Trade Size (Sh.) (30 D):	85
Avg Trade Size (Sh.) (90 D):	78

Institutional Trades
Total Institutional Trades:	865
Avg Institutional Trade:	$1.61M
Avg Institutional Trade (30 D):	$1.4M
Avg Institutional Trade (90 D):	$1.36M
Avg Institutional Trade Volume:	.15M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.8M
Avg Closing Trade (30 D):	$1.33M
Avg Closing Trade (90 D):	$1.49M
Avg Closing Volume:	163.36K

News

May 15, 2026 @ 10:00 AM ARS Pharmaceuticals Reports First Quarter 2026 Fin... Source: Ars Pharmaceuticals, Inc.

May 7, 2026 @ 12:00 PM ARS Pharmaceuticals Announces Conference Call and ... Source: Not Specified

Nov 10, 2025 @ 11:00 AM ARS Pharmaceuticals Reports Third Quarter 2025 Fin... Source: Ars Pharmaceuticals

Aug 13, 2025 @ 7:04 PM ARS Pharma Sales Jump 3,040% in Q2 Source: Jesterai

Jan 6, 2025 @ 1:00 PM ARS Pharmaceuticals Files for Approval of neffyÂÂ... Source: N/A

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-2	$-.61	$-.42
Diluted EPS	$-2	$-.61	$-.42
Revenue	$98.99M	$22.68M	$28.09M
Gross Profit
Net Income / Loss	$-197.98M	$-60.62M	$-41.32M
Operating Income / Loss	$-202.42M	$-60.15M	$-41.47M
Cost of Revenue
Net Cash Flow	$-15.54M	$-17M	$-18.24M
PE Ratio